Agency Information Collection Activities; Proposed eCollection eComments Requested; Registrant Record of Controlled Substances Destroyed, 99-100 [2023-28816]

Download as PDF khammond on DSKJM1Z7X2PROD with NOTICES Federal Register / Vol. 89, No. 1 / Tuesday, January 2, 2024 / Notices including antidumping or countervailing duties). If you are a trade/business association, provide the information, on an aggregate basis, for the firms which are members of your association. (a) Production (quantity) and, if known, an estimate of the percentage of total production of Subject Merchandise in the Subject Country accounted for by your firm’s(s’) production; (b) Capacity (quantity) of your firm(s) to produce the Subject Merchandise in the Subject Country (that is, the level of production that your establishment(s) could reasonably have expected to attain during the year, assuming normal operating conditions (using equipment and machinery in place and ready to operate), normal operating levels (hours per week/weeks per year), time for downtime, maintenance, repair, and cleanup, and a typical or representative product mix); and (c) the quantity and value of your firm’s(s’) exports to the United States of Subject Merchandise and, if known, an estimate of the percentage of total exports to the United States of Subject Merchandise from the Subject Country accounted for by your firm’s(s’) exports. (12) Identify significant changes, if any, in the supply and demand conditions or business cycle for the Domestic Like Product that have occurred in the United States or in the market for the Subject Merchandise in the Subject Country since the Order Dates, and significant changes, if any, that are likely to occur within a reasonably foreseeable time. Supply conditions to consider include technology; production methods; development efforts; ability to increase production (including the shift of production facilities used for other products and the use, cost, or availability of major inputs into production); and factors related to the ability to shift supply among different national markets (including barriers to importation in foreign markets or changes in market demand abroad). Demand conditions to consider include end uses and applications; the existence and availability of substitute products; and the level of competition among the Domestic Like Product produced in the United States, Subject Merchandise produced in the Subject Country, and such merchandise from other countries. (13) (OPTIONAL) A statement of whether you agree with the above definitions of the Domestic Like Product and Domestic Industry; if you disagree with either or both of these definitions, please explain why and provide alternative definitions. VerDate Sep<11>2014 15:59 Dec 29, 2023 Jkt 262001 Authority: This proceeding is being conducted under authority of Title VII of the Tariff Act of 1930; this notice is published pursuant to § 207.61 of the Commission’s rules. By order of the Commission. Issued: December 21, 2023. Lisa Barton, Secretary to the Commission. [FR Doc. 2023–28536 Filed 12–29–23; 8:45 am] BILLING CODE 7020–02–P JUDICIAL CONFERENCE OF THE UNITED STATES Advisory Committee on Appellate Rules; Hearing of the Judicial Conference Judicial Conference of the United States. ACTION: Advisory Committee on Appellate Rules; notice of cancellation of open hearing. AGENCY: The following public hearing on proposed amendments to the Federal Rules of Appellate Procedure has been canceled: Appellate Rules Hearing on January 24, 2024. DATES: January 24, 2024. FOR FURTHER INFORMATION CONTACT: H. Thomas Byron III, Esq., Chief Counsel, Rules Committee Staff, Administrative Office of the U.S. Courts, Thurgood Marshall Federal Judiciary Building, One Columbus Circle NE, Suite 7–300, Washington, DC 20544, Phone (202) 502–1820, RulesCommittee_Secretary@ ao.uscourts.gov. SUPPLEMENTARY INFORMATION: The announcement for this hearing was previously published in the Federal Register on August 9, 2023 at 88 FR 53917. SUMMARY: (Authority: 28 U.S.C. 2073.) Dated: December 27, 2023. Shelly L. Cox, Management Analyst, Rules Committee Staff. [FR Doc. 2023–28826 Filed 12–29–23; 8:45 am] BILLING CODE 2210–55–P DEPARTMENT OF JUSTICE [OMB Number 1117–0007] Agency Information Collection Activities; Proposed eCollection eComments Requested; Registrant Record of Controlled Substances Destroyed Drug Enforcement Administration, Department of Justice. ACTION: 30-Day notice. AGENCY: PO 00000 Frm 00057 Fmt 4703 Sfmt 4703 99 The Drug Enforcement Administration, Department of Justice (DOJ), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. This proposed information collection was previously published in the Federal Register on October 26, 2023, allowing for a 60-day comment period. DATES: Comments are encouraged and will be accepted for 30 days until February 1, 2023. FOR FURTHER INFORMATION CONTACT: If you have comments especially on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions or additional information, please contact Scott A. Brinks, Regulatory Drafting and Policy Support Section, Drug Enforcement Administration; Mailing Address: 8701 Morrissette Drive, Springfield, Virginia 22152; Telephone: (571) 362–3261; email: DPW@dea.gov. SUPPLEMENTARY INFORMATION: Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: —Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; —Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; —Enhance the quality, utility, and clarity of the information to be collected; and/or —Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. SUMMARY: Written comments and recommendations for this information collection should be submitted within 30 days of the publication of this notice on the following website www.reginfo.gov/public/do/PRAMain. Find this particular information collection by selecting ‘‘Currently under E:\FR\FM\02JAN1.SGM 02JAN1 100 Federal Register / Vol. 89, No. 1 / Tuesday, January 2, 2024 / Notices khammond on DSKJM1Z7X2PROD with NOTICES 30-day Review—Open for Public Comments’’ or by using the search function and entering either the title of the information collection or the OMB Control Number 1117–0007. This information collection request may be viewed at www.reginfo.gov. Follow the instructions to view Department of Justice, information collections currently under review by OMB. DOJ seeks PRA authorization for this information collection for three (3) years. OMB authorization for an ICR cannot be for more than three (3) years without renewal. The DOJ notes that information collection requirements submitted to the OMB for existing ICRs receive a month-to-month extension while they undergo review. Overview of This Information Collection 1. Type of Information Collection: Extension of a currently approved collection. 2. Title of the Form/Collection: Registrant Record of Controlled Substances Destroyed. 3. Agency form number, if any, and the applicable component of the Department of Justice sponsoring the collection: DEA From 41. The applicable component within the Department of Justice is the Drug Enforcement Administration, Diversion Control Division. 4. Affected public who will be asked or required to respond, as well as a brief abstract: Affected public (Primary): Private Sector—business or other for-profit. Affected public (Other): Not-for-profit institutions; Federal, State, local, and tribal governments. Abstract: In accordance with the Controlled Substance Act (CSA), every DEA registrant must make a biennial inventory and maintain, on a current basis, a complete and accurate record of each controlled substance manufactured, received, sold, delivered, or otherwise disposed of. 21 U.S.C. 827 and 958. These records must be maintained separately from all other records of the registrant or, alternatively, in the case of non-narcotic controlled substances, be in such form that required information is readily retrievable from the ordinary business records of the registrant per 21 U.S.C. 827(b)(2). The records must be kept and be available for at least two years for inspection and copying by officers or employees of the United States authorized by the Attorney General. 21 U.S.C. 827(b)(3). The records must be in accordance with and contain such relevant information as may be required by regulations promulgated by DEA. 21 VerDate Sep<11>2014 15:59 Dec 29, 2023 Jkt 262001 U.S.C. 827(b)(1). These record requirements help to deter and detect diversion of controlled substances and ensure that registrants remain accountable for all controlled substances within their possession and/ or control. 5. Obligation to Respond: Mandatory per 21 CFR 1314. 6. Total Estimated Number of Respondents: 92,832. 7. Estimated Time per Respondent: 30 minutes for DEA Form 41. 8. Frequency: DEA Form 41 is 1 per year. 9. Total Estimated Annual Time Burden: 46,416 hours. 10. Total Estimated Annual Other Costs Burden: $0. If additional information is required, contact: Darwin Arceo, Department Clearance Officer, Policy and Planning Staff, Justice Management Division, United States Department of Justice, Two Constitution Square, 145 N Street NE, 4W–218, Washington, DC 20530. Dated: December 27, 2023. Darwin Arceo, Department Clearance Officer for PRA, U.S. Department of Justice. [FR Doc. 2023–28816 Filed 12–29–23; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE [OMB Number 1117–0046] Agency Information Collection Activities; Proposed eCollection eComments Requested; SelfCertification, Training, and Logbooks for Regulated Sellers and Mail-Order Distributors of Scheduled Listed Chemicals Products Drug Enforcement Administration, Department of Justice. ACTION: 30-Day notice. AGENCY: The Drug Enforcement Administration (DEA), Department of Justice (DOJ), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. This proposed information collection was previously published in the Federal Register on October 26, 2023, allowing for a 60-day comment period. DATES: Comments are encouraged and will be accepted for 30 days until February 1, 2023. FOR FURTHER INFORMATION CONTACT: If you have comments especially on the estimated public burden or associated response time, suggestions, or need a SUMMARY: PO 00000 Frm 00058 Fmt 4703 Sfmt 4703 copy of the proposed information collection instrument with instructions or additional information, please contact Scott A. Brinks, Regulatory Drafting and Policy Support Section, Drug Enforcement Administration; Mailing Address: 8701 Morrissette Drive, Springfield, Virginia 22152; Telephone: (571) 362–3261, email: DPW@dea.gov. SUPPLEMENTARY INFORMATION: Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: —Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; —Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; —Enhance the quality, utility, and clarity of the information to be collected; and/or —Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. Written comments and recommendations for this information collection should be submitted within 30 days of the publication of this notice on the following website www.reginfo.gov/public/do/PRAMain. Find this particular information collection by selecting ‘‘Currently under 30-day Review—Open for Public Comments’’ or by using the search function and entering either the title of the information collection or the OMB Control Number 1117–0046. This information collection request may be viewed at www.reginfo.gov. Follow the instructions to view Department of Justice, information collections currently under review by OMB. DOJ seeks PRA authorization for this information collection for three (3) years. OMB authorization for an ICR cannot be for more than three (3) years without renewal. The DOJ notes that information collection requirements submitted to the OMB for existing ICRs receive a month-to-month extension while they undergo review. E:\FR\FM\02JAN1.SGM 02JAN1

Agencies

[Federal Register Volume 89, Number 1 (Tuesday, January 2, 2024)]
[Notices]
[Pages 99-100]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-28816]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

[OMB Number 1117-0007]


Agency Information Collection Activities; Proposed eCollection 
eComments Requested; Registrant Record of Controlled Substances 
Destroyed

AGENCY: Drug Enforcement Administration, Department of Justice.

ACTION: 30-Day notice.

-----------------------------------------------------------------------

SUMMARY: The Drug Enforcement Administration, Department of Justice 
(DOJ), will be submitting the following information collection request 
to the Office of Management and Budget (OMB) for review and approval in 
accordance with the Paperwork Reduction Act of 1995. This proposed 
information collection was previously published in the Federal Register 
on October 26, 2023, allowing for a 60-day comment period.

DATES: Comments are encouraged and will be accepted for 30 days until 
February 1, 2023.

FOR FURTHER INFORMATION CONTACT: If you have comments especially on the 
estimated public burden or associated response time, suggestions, or 
need a copy of the proposed information collection instrument with 
instructions or additional information, please contact Scott A. Brinks, 
Regulatory Drafting and Policy Support Section, Drug Enforcement 
Administration; Mailing Address: 8701 Morrissette Drive, Springfield, 
Virginia 22152; Telephone: (571) 362-3261; email: [email protected].

SUPPLEMENTARY INFORMATION: Written comments and suggestions from the 
public and affected agencies concerning the proposed collection of 
information are encouraged. Your comments should address one or more of 
the following four points:

--Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the agency, including 
whether the information will have practical utility;
--Evaluate the accuracy of the agency's estimate of the burden of the 
proposed collection of information, including the validity of the 
methodology and assumptions used;
--Enhance the quality, utility, and clarity of the information to be 
collected; and/or
--Minimize the burden of the collection of information on those who are 
to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submission of responses.

    Written comments and recommendations for this information 
collection should be submitted within 30 days of the publication of 
this notice on the following website www.reginfo.gov/public/do/PRAMain. 
Find this particular information collection by selecting ``Currently 
under

[[Page 100]]

30-day Review--Open for Public Comments'' or by using the search 
function and entering either the title of the information collection or 
the OMB Control Number 1117-0007. This information collection request 
may be viewed at www.reginfo.gov. Follow the instructions to view 
Department of Justice, information collections currently under review 
by OMB.
    DOJ seeks PRA authorization for this information collection for 
three (3) years. OMB authorization for an ICR cannot be for more than 
three (3) years without renewal. The DOJ notes that information 
collection requirements submitted to the OMB for existing ICRs receive 
a month-to-month extension while they undergo review.

Overview of This Information Collection

    1. Type of Information Collection: Extension of a currently 
approved collection.
    2. Title of the Form/Collection: Registrant Record of Controlled 
Substances Destroyed.
    3. Agency form number, if any, and the applicable component of the 
Department of Justice sponsoring the collection: DEA From 41. The 
applicable component within the Department of Justice is the Drug 
Enforcement Administration, Diversion Control Division.
    4. Affected public who will be asked or required to respond, as 
well as a brief abstract:
    Affected public (Primary): Private Sector--business or other for-
profit.
    Affected public (Other): Not-for-profit institutions; Federal, 
State, local, and tribal governments.
    Abstract: In accordance with the Controlled Substance Act (CSA), 
every DEA registrant must make a biennial inventory and maintain, on a 
current basis, a complete and accurate record of each controlled 
substance manufactured, received, sold, delivered, or otherwise 
disposed of. 21 U.S.C. 827 and 958. These records must be maintained 
separately from all other records of the registrant or, alternatively, 
in the case of non-narcotic controlled substances, be in such form that 
required information is readily retrievable from the ordinary business 
records of the registrant per 21 U.S.C. 827(b)(2). The records must be 
kept and be available for at least two years for inspection and copying 
by officers or employees of the United States authorized by the 
Attorney General. 21 U.S.C. 827(b)(3). The records must be in 
accordance with and contain such relevant information as may be 
required by regulations promulgated by DEA. 21 U.S.C. 827(b)(1). These 
record requirements help to deter and detect diversion of controlled 
substances and ensure that registrants remain accountable for all 
controlled substances within their possession and/or control.
    5. Obligation to Respond: Mandatory per 21 CFR 1314.
    6. Total Estimated Number of Respondents: 92,832.
    7. Estimated Time per Respondent: 30 minutes for DEA Form 41.
    8. Frequency: DEA Form 41 is 1 per year.
    9. Total Estimated Annual Time Burden: 46,416 hours.
    10. Total Estimated Annual Other Costs Burden: $0.
    If additional information is required, contact: Darwin Arceo, 
Department Clearance Officer, Policy and Planning Staff, Justice 
Management Division, United States Department of Justice, Two 
Constitution Square, 145 N Street NE, 4W-218, Washington, DC 20530.

    Dated: December 27, 2023.
Darwin Arceo,
Department Clearance Officer for PRA, U.S. Department of Justice.
[FR Doc. 2023-28816 Filed 12-29-23; 8:45 am]
BILLING CODE 4410-09-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.